Although the humanized mouse model described herein is well suited to evaluate therapeutic interventions that mitigate active HIV replication and CD4+ T cell depletion, these animals eventually develop graft- versus-host disease (GVHD).72 The gene discussed is CD4; the disease is graft versus host disease.